Name: UMIN ID:
Unique ID issued by UMIN | UMIN000024528 |
---|---|
Receipt number | R000028208 |
Scientific Title | First-line single-agent Panitumumab in the Japanese frail patients with wild-type RAS unresectable colorectal cancer: A phase II study(OGSG 1602) |
Date of disclosure of the study information | 2016/12/01 |
Last modified on | 2022/09/25 22:30:06 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/10/23 23:17:47 | ||
2 | Update | 2017/05/31 21:14:48 | Recruitment status |
|
3 | Update | 2017/07/16 17:35:08 | Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2017/10/02 23:30:03 | Last follow-up date |
|
5 | Update | 2017/10/26 20:28:43 | Email |
|
6 | Update | 2018/04/26 23:24:35 | Institutions |
|
7 | Update | 2018/08/01 06:47:30 | UMIN ID1 |
|
8 | Update | 2018/08/03 18:40:26 | Recruitment status Anticipated trial start date Last follow-up date |
|
9 | Update | 2018/08/19 21:01:42 | Last follow-up date |
|
10 | Update | 2018/10/25 23:06:47 | Last follow-up date |
|
11 | Update | 2019/10/30 22:38:05 | URL releasing protocol Number of participants that the trial has enrolled |
|
12 | Update | 2020/01/05 21:29:56 | Date of IRB |
|
13 | Update | 2020/11/02 07:17:13 | Recruitment status Date analysis concluded |
|
14 | Update | 2020/11/24 14:34:17 | Publication of results Results Results Results date posted Date of the first journal publication of results |
|
15 | Update | 2020/11/24 14:38:13 | Recruitment status |
|
16 | Update | 2022/09/25 22:29:05 | URL related to results and publications Results Results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
17 | Update | 2022/09/25 22:30:06 | Publication of results |